Sutro Biopharma Preferred Securities out of Shareholders Equity (Quarterly) Analysis

Sutro Biopharma, Inc. (STRO)

14.92 +1.10 (+7.96%) USD | NASDAQ | Jan 20, 16:00

14.63 -0.29 (-1.94%) After-Hours: 20:00

View Preferred Securities out of Shareholders Equity (Quarterly) for STRO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Preferred Securities out of Shareholders Equity (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks

Start Trial

GT Biopharma, Inc.	--
Daré Bioscience, Inc.	--
Syndax Pharmaceuticals, Inc.	--
Crinetics Pharmaceuticals, Inc.	--
NovaBay Pharmaceuticals, Inc.	--